Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CLEARPOINT NEURO, INC.

(CLPT)
  Rapport
Geschatte realtime Cboe BZX  -  15:44 28-09-2022
10.10 USD   -0.25%
23/09Het Zweedse Clinical Laserthermia Systems stijgt met 25% na goedkeuring door de Amerikaanse FDA van het neurolasertherapiesysteem.
MT
23/09ClearPoint Neuro, Inc. Kondigt FDA-goedkeuring aan voor ClearPoint Prism™ Neuro Laser Therapy System
CI
20/09ClearPoint Neuro, Inc. Kondigt de benoeming aan van Mazin Sabra als Chief Operating Officer
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op CLEARPOINT NEURO, INC.
23/09Sweden's Clinical Laserthermia Systems Soars 25% on US FDA Clearance for Neuro Laser Th..
23/09ClearPoint Neuro Says Partner Received FDA Clearance for Neuro Laser Therapy System
23/09Clinical Laserthermia Systems receives FDA 510(k) clearance for its MR guided laser abl..
23/09ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therap..
23/09ClearPoint Neuro, Inc. Announces FDA Clearance for ClearPoint Prism™ Neuro Laser T..
20/09ClearPoint Neuro Appoints Mazin Sabra Chief Operating Officer
20/09Clearpoint Neuro, Inc. : Change in Directors or Principal Officers, Regulation FD Disclosu..
20/09ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer
20/09ClearPoint Neuro, Inc. Announces Appointment of Mazin Sabra as Chief Operating Officer
19/09ClearPoint Neuro Gets FDA Clearance for Navigation Software Version 2.1
19/09ClearPoint Neuro Announces FDA Clearance for Software Version 2.1
19/09ClearPoint Neuro, Inc. Announces FDA Clearance for Software Version 2.1
16/08Insider Sell: Clearpoint Neuro
10/08CLEARPOINT NEURO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
09/08ClearPoint Says FDA Clears Maestro Brain Model, Shares Rise 6%
09/08Clearpoint Neuro : Reports Second Quarter 2022 Results - Form 8-K
09/08Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q2 Revenue $5.2M
09/08Transcript : ClearPoint Neuro, Inc., Q2 2022 Earnings Call, Aug 09, 2022
09/08Clearpoint Neuro, Inc. : Results of Operations and Financial Condition, Regulation FD Disc..
09/08ClearPoint Neuro Reports Second Quarter 2022 Results
09/08ClearPoint Neuro, Inc. Reports Earnings Results for the Second Quarter and Six Months E..
09/08ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Full Year 2022
09/08ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model
09/08ClearPoint Neuro, Inc. Announces FDA Clearance for ClearPoint Maestro™ Brain Model
08/08ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice Preside..
26/07ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022
22/07ClearPoint Neuro félicite son partenaire PTC Therapeutics pour l'obtention de l'autoris..
22/07ClearPoint Neuro félicite son partenaire PTC Therapeutics pour l'obtention de l'autoris..
22/07ClearPoint Neuro beglückwünscht Partner PTC Therapeutics für den Erhalt der Marktzulass..
21/07ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Auth..
21/07ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Auth..
29/06ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in Fir..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
24/06ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russe..
06/06Clearpoint Neuro, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
02/06ClearPoint Neuro Announces Receipt of MDSAP Certification
26/05Clearpoint Neuro, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
23/05Clearpoint Neuro, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
20/05ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opin..
19/05Clearpoint Neuro, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul..
19/05ClearPoint Neuro, Inc. Reconstitutes its Committees
13/05ClearPoint Neuro to Present Investigational Research and Exhibit at the American Societ..
11/05CLEARPOINT NEURO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
11/05ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
11/05Transcript : ClearPoint Neuro, Inc., Q1 2022 Earnings Call, May 11, 2022
11/05Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $5M, vs. Street Est of $4.18M
11/05Clearpoint Neuro, Inc. : Results of Operations and Financial Condition, Regulation FD Disc..
11/05ClearPoint Neuro Reports First Quarter 2022 Results
11/05ClearPoint Neuro, Inc. Revises Revenue Guidance for the Year 2022
03/05ClearPoint Neuro and Higgs Boson Health Announce Collaboration
03/05ClearPoint Neuro, Inc. and Higgs Boson Health Announce Collaboration
28/04ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1
28/04ClearPoint Neuro, Inc. Announces FDA Clearance of the SmartFrame Array™ Version 1...
27/04ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power ..
27/04ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power ..
26/04ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022
29/03ClearPoint Neuro to Present at the B. Riley Securities Disruptive Biotech Enabling Tech..
09/03CLEARPOINT NEURO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
01/03Transcript : ClearPoint Neuro, Inc., Q4 2021 Earnings Call, Mar 01, 2022
01/03Clearpoint Neuro : Reports Fourth Quarter and Full-Year 2021 Results Company Reports Recor..
01/03ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results
01/03Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q4 Revenue $16.3M, vs. Street Est of $4...
01/03ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 20..
15/02Clearpoint Neuro : Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results a..
15/02Clearpoint Neuro, Inc. : Results of Operations and Financial Condition, Regulation FD Disc..
15/02ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results ..
15/02ClearPoint Neuro, Inc. Provides Revenue Guidance for the Year of 2022
14/02Clearpoint Neuro, Inc. : Change in Directors or Principal Officers, Financial Statements a..
14/02ClearPoint Neuro, Inc. Announces Resignation of Peter G. Piferi as Chief Operating Offi..
05/01ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT Virtual Conference
2021CLS has filed its 510 (k) application with the U.S. Food and Drug Administration (FDA) ..
2021Clearpoint Neuro, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
2021ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Des..
2021ClearPoint Neuro, Inc. Congratulates Blackrock Neurotech on Receiving Breakthrough Devi..
2021ClearPoint Neuro, Inc. Presents at Stifel 2021 Virt..
2021CLEARPOINT NEURO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
2021ClearPoint Neuro Reports Third Quarter 2021 Results Record Revenue Achieved; Company Re..
2021ClearPoint Neuro, Inc., Q3 2021 Earnings Call, Nov 09, 2021
2021Clearpoint Neuro, Inc. : Results of Operations and Financial Condition, Regulation FD Disc..
2021ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months E..
2021ClearPoint Neuro Reports Third Quarter 2021 Results
2021Earnings Flash (CLPT) CLEARPOINT NEURO Posts Q3 Revenue $4.57M, vs. Street Est of $4M
2021ClearPoint Neuro, Inc. Provides Earnings Guidance for the Year 2021
2021Earnings Reaction History: ClearPoint Neuro Inc, 66.7% Follow-..
2021ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Th..
2021ClearPoint Neuro to Present at the 2021 Stifel Virtual Healthcare Conference
2021Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joi..
2021Clearpoint Neuro, Inc. : Change in Directors or Principal Officers, Regulation FD Disclosu..
2021Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joi..
2021ClearPoint Neuro, Inc. Appoints Linda M. Liau to its Board of Directors
2021ClearPoint Neuro to Announce Third Quarter 2021 Results November 9, 2021
Volgende evenement op CLEARPOINT NEURO, INC.